This article describes the design and development of a low-cost, portable monitoring system for indoor environment quality (IEQ). IEQ is a holistic concept that encompasses elements of indoor air quality (IAQ), indoor lighting quality (ILQ), acoustic comfort, and thermal comfort (temperature and relative humidity). The unit is intended for the monitoring of temperature, humidity, PM2.5, PM10, total VOCs (×3), CO₂, CO, illuminance, and sound levels. Experiments were conducted in various environments, including a typical indoor working environment and outdoor pollution, to evaluate the unit’s potential to monitor IEQ parameters. The developed system was successfully able to monitor parameter variations, based on specific events. A custom IEQ index was devised to rate the parameter readings with a simple scoring system to calculate an overall IEQ percentage. The advantages of the proposed system, with respect to commercial units, is associated with better customisation and flexibility to implement a variety of low-cost sensors. Moreover, low-cost sensor modules reduce the overall cost to provide a comprehensive, portable, and real-time monitoring solution. This development facilities researchers and interested enthusiasts to become engaged and proactive in participating in the study, management, and improvement of IEQ.

The electronic nose (eNose) is an instrument designed to mimic the human olfactory system. Usage of eNose in medical applications is more popular than ever, due to its low costs and non-invasive nature. The eNose sniffs the gases and vapours that emanate from human waste (urine, breath, and stool) for the diagnosis of variety of diseases. Diabetes mellitus type 2 (DM2) affects 8.3% of adults in the world, with 43% being underdiagnosed, resulting in 4.9 million deaths per year. In this study, we investigated the potential of urinary volatile organic compounds (VOCs) as novel non-invasive diagnostic biomarker for diabetes. In addition, we investigated the influence of sample age on the diagnostic accuracy of urinary VOCs. We analysed 140 urine samples (73 DM2, 67 healthy) with Field-Asymmetric Ion Mobility Spectrometry (FAIMS); a type of eNose; and FOX 4000 (AlphaM.O.S, Toulouse, France). Urine samples were collected at UHCW NHS Trust clinics over 4 years and stored at −80 °C within two hours of collection. Four different classifiers were used for classification, specifically Sparse Logistic Regression, Random Forest, Gaussian Process, and Support Vector on both FAIMS and FOX4000. Both eNoses showed their capability of diagnosing DM2 from controls and the effect of sample age on the discrimination. FAIMS samples were analysed for all samples aged 0–4 years (AUC: 88%, sensitivity: 87%, specificity: 82%) and then sub group samples aged less than a year (AUC (Area Under the Curve): 94%, Sensitivity: 92%, specificity: 100%). FOX4000 samples were analysed for all samples aged 0–4 years (AUC: 85%, sensitivity: 77%, specificity: 85%) and a sub group samples aged less than 18 months: (AUC: 94%, sensitivity: 90%, specificity: 89%). We demonstrated that FAIMS and FOX 4000 eNoses can discriminate DM2 from controls using urinary VOCs. In addition, we showed that urine sample age affects discriminative accuracy.

Electronic nose (E-nose) technology provides an easy and inexpensive way to analyse chemical samples. In recent years, there has been increasing demand for E-noses in applications such as food safety, environmental monitoring and medical diagnostics. Currently, the majority of E-noses utilise an array of metal oxide (MOX) or conducting polymer (CP) gas sensors. However, these sensing technologies can suffer from sensor drift, poor repeatability and temperature and humidity effects. Optical gas sensors have the potential to overcome these issues. This paper reports on the development of an optical non-dispersive infrared (NDIR) E-nose, which consists of an array of four tuneable detectors, able to scan a range of wavelengths (3.1–10.5 μm). The functionality of the device was demonstrated in a series of experiments, involving gas rig tests for individual chemicals (CO₂ and CH₄), at different concentrations, and discriminating between chemical standards and complex mixtures. The optical gas sensor responses were shown to be linear to polynomial for different concentrations of CO₂ and CH₄. Good discrimination was achieved between sample groups. Optical E-nose technology therefore demonstrates significant potential as a portable and low-cost solution for a number of E-nose applications.

The medical profession is becoming ever more interested in the use of gas-phase biomarkers for disease identification and monitoring. This is due in part to its rapid analysis time and low test cost, which makes it attractive for many different clinical arenas. One technology that is showing promise for analyzing these gas-phase biomarkers is the electronic nose—an instrument designed to replicate the biological olfactory system. Of the possible biological media available to “sniff”, urine is becoming ever more important as it is easy to collect and to store for batch testing. However, this raises the question of sample storage shelf-life, even at −80 °C. Here we investigated the effect of storage time (years) on stability and reproducibility of total gas/vapour emissions from urine samples. Urine samples from 87 patients with Type 2 Diabetes Mellitus were collected over a four-year period and stored at −80 °C. These samples were then analyzed using FAIMS (field-asymmetric ion mobility spectrometry—a type of electronic nose). It was discovered that gas emissions (concentration and diversity) reduced over time. However, there was less variation in the initial nine months of storage with greater uniformity and stability of concentrations together with tighter clustering of the total number of chemicals released. This suggests that nine months could be considered a general guide to a sample shelf-life.

The measurement of disease biomarkers in easily–obtained bodily fluids has opened the door to a new type of non–invasive medical diagnostics. New technologies are being developed and fine–tuned in order to make this possibility a reality. One such technology is Field Asymmetric Ion Mobility Spectrometry (FAIMS), which allows the measurement of volatile organic compounds (VOCs) in biological samples such as urine. These VOCs are known to contain a range of information on the relevant person’s metabolism and can in principle be used for disease diagnostic purposes. Key to the effective use of such data are well–developed data processing pipelines, which are necessary to extract the most useful data from the complex underlying biological structure. In this study, we present a new data analysis pipeline for FAIMS data, and demonstrate a number of improvements over previously used methods. We evaluate the effect of a series of candidate operational steps during data processing, such as the use of wavelet transforms, principal component analysis (PCA), and classifier ensembles. We also demonstrate the use of FAIMS data in our pipeline to diagnose diabetes on the basis of a simple urine sample using machine learning classifiers. We present results for data generated from a case-control study of 115 urine samples, collected from 72 type II diabetic patients, with 43 healthy volunteers as negative controls. The resulting pipeline combines the steps that resulted in the best classification model performance. These include the use of a two–dimensional discrete wavelet transform, and the Wilcoxon rank–sum test for feature selection. We are able to achieve a best ROC curve AUC of 0.825 (0.747–0.9, 95% CI) for classification of diabetes vs control. We also note that this result is robust to changes in the data pipeline and different analysis runs, with AUC > 0.80 achieved in a range of cases. This is a substantial improvement in performance over previously used data processing methods in this area. Our ability to make strong statements about FAIMS ability to diagnose diabetes is sadly limited, as we found confounding effects from the demographics when including these data in the pipeline. The demographics alone produced a best AUC of 0.87 (0.795–0.94, 95% CI). While the combination of the demographics and FAIMS data resulted in an improvement on the AUC (0.907; 0.848–0.97, 95% CI), it did not prove to be a significant difference. Nevertheless, the pipeline itself shows a significant improvement in performance over more basic methods which have been used with FAIMS data in the past.

Pollution by particulate matter (PM) poses a serious and growing risk to human health. Film Bulk Acoustic Resonators (FBARs) have been proposed as a low-cost way to monitor particle concentration. This paper presents particle detection by a 1.1 GHz aluminium nitride based FBAR designed and fabricated by SilTerra Malaysia. The FBARs are used in a differential configuration with one sensing and one reference device in a system comprising a microchannel with an electric microfan and a thermophoretic precipitator microhotplate array for improved sampling. A custom-built test chamber was designed to characterise the device at different levels of particulate matter concentration in air. The particle feed rate into the test chamber was varied between 9.5, 19, 43, 66 and 94 μg/m ³ s. The FBAR frequency was found to decrease with increasing particulate matter concentration in the test chamber air. The experiments were conducted with and without the microchannel and it was found that the sampling channel increased sensitivity of FBAR resonant frequency to particle concentration per cubic meter of air from 5 Hz/ μgm ^-3 to 20 Hz/ μgm ^-3 . The detection limit in this test was estimated at ca. 50 μg/m ³ , which is around current European limits for PM10 pollution. In addition, the use of the sampling microfan to aid cleaning of FBARs after particle measurement was also investigated and found to be feasible especially for lower particle concentration.